Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Neurocrine Biosciences Inc (NASDAQ:NBIX)

43.28
Delayed Data
As of Jun 24
 -1.31 / -2.94%
Today’s Change
31.25
Today|||52-Week Range
58.46
-23.49%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Gano Kyle
Chief Business Development Officer
Sale4/11/201639,845$44.04$1.8M-2.44%
Gorman Kevin Charles
President & Chief Executive Officer
Sale10/16/201533,500$47.77$1.6M-10.89%
Lippoldt Darin M
Chief Legal Officer
Sale11/09/201523,761$52.92$1.3M-18.68%
Bozigian Haig P
Chief Development Officer
Sale10/16/201525,000$47.78$1.2M-10.89%
Coughlin Timothy P
Chief Financial Officer
Sale10/16/201525,000$47.78$1.2M-10.89%
Obrien Christopher Flint
Chief Medical Officer
Sale10/16/201525,000$47.78$1.2M-10.89%
Gano Kyle
Chief Business Development Officer
Sale10/16/201525,000$47.77$1.2M-10.89%
Grigoriadis Dimitri E
Chief Research Officer
Sale10/16/201525,000$47.77$1.2M-10.89%
Obrien Christopher Flint
Chief Medical Officer
Sale4/06/201625,000$45.00$1.1M-8.13%
Obrien Christopher Flint
Chief Medical Officer
Sale5/16/201625,000$45.00$1.1M-6.42%
Page of 7